A new version of this entry is available:
Loading...
ResearchPaper
2013
Inter-firm R&D networks in pharmaceutical biotechnology : what determines firm's centrality-based partnering capability?
Inter-firm R&D networks in pharmaceutical biotechnology : what determines firm's centrality-based partnering capability?
Abstract (English)
This paper analyses the inter-firm R&D network formed in the pharmaceutical
biotechnology industry during the 1990s from different perspectives: theoretical network formation, firm's structural positions and its collaborations at the entire network level, and the determinants for firm's centrality-based partnering capability. The results indicate that pharmaceutical biotechnology industry has experienced a significant evolutional change in size and structure during 1991-1998. By considering individual structural positions, the descriptive statistics show that in the 1990s, established pharmaceutical companies developed into dominant star players with multiple partnerships while holding central roles in the R&D network. In the network analysis that emphasized aggregate network level, the degree-based and betweenness-based network centralization were not high implying that the distribution of overall positional advantages in the pharmaceutical biotechnology industry is, to a large degree, not unequal and even though most firms in this sector are linked to the R&D network, some of them are more active than others. The current analysis also shows that firm's efficiency, firm's dependency on its complementary resources and firm's experiences at managing partnerships are important determinants for firm's centrality-based partnering capability, which has important managerial implications for understanding firm's strategic partnering behaviour.
File is subject to an embargo until
This is a correction to:
A correction to this entry is available:
This is a new version of:
Notes
Publication license
Publication series
FZID discussion papers; 75
Published in
Faculty
Faculty of Business, Economics and Social Sciences
State Institutes
State Institutes
Institute
Institute of Economics
Forschungszentrum Innovation und Dienstleistung
Forschungszentrum Innovation und Dienstleistung
Examination date
Supervisor
Edition / version
Citation
Identification
DOI
ISSN
ISBN
Language
English
Publisher
Publisher place
Classification (DDC)
330 Economics
Original object
Standardized keywords (GND)
BibTeX
@techreport{Schwalbe2013,
url = {https://hohpublica.uni-hohenheim.de/handle/123456789/5712},
author = {Schwalbe, Ulrich and Riedel, Nadine and Krogmann, Yin et al.},
title = {Inter-firm R&D networks in pharmaceutical biotechnology : what determines firm's centrality-based partnering capability?},
year = {2013},
school = {Universität Hohenheim},
series = {FZID discussion papers},
}